Skip to content

Contact +44 (0) 20 7060 7474 email us

Search Results


The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Levofloxacin: Pipeline™ Developer'

Title Publication Date Price Relevance
Levofloxacin
Pipeline Developer
Ongoing £3795 100 %
Levofloxacin: Extended Country Coverage
Pipeline Selector
Ongoing £610 96 %
Levofloxacin: Core Country Coverage
Pipeline Selector
Ongoing £260 96 %
Commercial Insight: Antibacterials
Growth in resistance rates drives niche indications
December 2006 £8000 50 %
Commercial Insight Antibacterials
Growth in resistance rates drives niche indications
January 2007 £8000 49.5 %
Daiichi Sankyo: Pipeline, Products, Performance, Potential
June 2008 £595 34.65 %
Daiichi Sankyo
Pipeline, Products, Performance, Potential
October 2008 £595 34.65 %
Johnson & Johnson Prospects to 2010
June 2007 £595 30.8 %
Collagens Clinical Trial Analysis
July 2009 £635 30.45 %
Sawai Pharmaceuticals Generics Company Intelligence Report
Company Intelligence Report
March 2009 £195 21.35 %
Mylan Generics Company Intelligence Report
Company Intelligence Report
March 2009 £195 13.3 %
Stakeholder Opinions: Skin and soft tissue infections
July 2009 £3800 13.3 %
Antibiotics
Global Trends
November 2009 £1905 9.1 %
Stakeholder Opinions: Cystic Fibrosis - A pipeline full of hope
Healthcare
March 2009 £2000 8.75 %
Anti Infectives, Vol II: Antibacterials
April 2007 £1905 7.7 %
Generic Competition, 2007–11
The impact of patent expiries on sales of major drugs
February 2007 £1375 7.7 %
Injectable Generic Drugs
Prospects & Opportunities to 2013
July 2008 £1295 7.35 %
Stakeholder Insight: Respiratory Tract Infections in the USA
The demise of narrow-spectrum antibiotics
November 2006 £8000 7 %
Stakeholder Insight: Respiratory Tract Infections in the USA
The demise of narrow-spectrum antibiotics
November 2006 £8000 7 %
Handbook of Pharmaceutical Manufacturing Formulations - Vol 1 of 6
Compressed Solid Products
April 2007 £195 5.25 %